Malignant Anorectal Neoplasm — Trials

Malignant Anorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 250
Ph III recruiting: 38
Growth YoY: +4.6%
Industry share: 6%
Top sponsor: Fudan University
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (174)

clinicaltrialsPublishedShowing 1,101–1,150 of 1,783 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04664504	A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk	unknown	Phase 2	150	Jing Jin, M.D.UNKNOWN	1	Jun 8, 2021	clinicaltrials
NCT04917263	IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.(IMMUNOREACT2)	unknown	—	544	University of PadovaOTHER	1	Jun 8, 2021	clinicaltrials